Higher risk of progression to dementia in mild cognitive impairment cases who revert to normal

Rosebud O Roberts, David S Knopman, Michelle M Mielke, Ruth H. Cha, V. Shane Pankratz, Teresa J H Christianson, Yonas Endale Geda, Bradley F Boeve, Robert J. Ivnik, Eric George Tangalos, Walter A Rocca, Ronald Carl Petersen

Research output: Contribution to journalArticle

145 Citations (Scopus)

Abstract

Objective: To estimate rates of progression from mild cognitive impairment (MCI) to dementia and of reversion from MCI to being cognitively normal (CN) in a population-based cohort. Methods: Participants (n 5 534, aged 70 years and older) enrolled in the prospective Mayo Clinic Study of Aging were evaluated at baseline and every 15 months to identify incident MCI or dementia. Results: Over a median follow-up of 5.1 years, 153 of 534 participants (28.7%) with prevalent or incident MCI progressed to dementia (71.3 per 1,000 person-years). The cumulative incidence of dementia was 5.4% at 1 year, 16.1% at 2, 23.4% at 3, 31.1% at 4, and 42.5%at 5 years. The risk of dementia was elevated in MCI cases (hazard ratio [HR] 23.2, p , 0.001) compared with CN subjects. Thirty-eight percent (n 5 201) of MCI participants reverted to CN (175.0/1,000 person-years), but 65% subsequently developed MCI or dementia; the HR was 6.6 (p , 0.001) compared with CN subjects. The risk of reversion was reduced in subjects with an APOE e4 allele (HR 0.53, p , 0.001), higher Clinical Dementia Rating Scale-Sum of Boxes (HR 0.56, p , 0.001), and poorer cognitive function (HR 0.56, p , 0.001). The risk was also reduced in subjects with amnestic MCI (HR 0.70, p 5 0.02) and multidomain MCI (HR 0.61, p 5 0.003). Conclusions: MCI cases, including thosewho revert to CN, have a high risk of progressing to dementia. This suggests that diagnosis of MCI at any time has prognostic value.

Original languageEnglish (US)
Pages (from-to)317-325
Number of pages9
JournalNeurology
Volume82
Issue number4
DOIs
StatePublished - Jan 28 2014

Fingerprint

Dementia
Cognitive Dysfunction
Mild Cognitive Impairment
Progression
Hazard
Cognition
Alleles
Incidence

ASJC Scopus subject areas

  • Clinical Neurology
  • Arts and Humanities (miscellaneous)

Cite this

Higher risk of progression to dementia in mild cognitive impairment cases who revert to normal. / Roberts, Rosebud O; Knopman, David S; Mielke, Michelle M; Cha, Ruth H.; Pankratz, V. Shane; Christianson, Teresa J H; Geda, Yonas Endale; Boeve, Bradley F; Ivnik, Robert J.; Tangalos, Eric George; Rocca, Walter A; Petersen, Ronald Carl.

In: Neurology, Vol. 82, No. 4, 28.01.2014, p. 317-325.

Research output: Contribution to journalArticle

@article{b1aed450836249818c9f71e09b9914c3,
title = "Higher risk of progression to dementia in mild cognitive impairment cases who revert to normal",
abstract = "Objective: To estimate rates of progression from mild cognitive impairment (MCI) to dementia and of reversion from MCI to being cognitively normal (CN) in a population-based cohort. Methods: Participants (n 5 534, aged 70 years and older) enrolled in the prospective Mayo Clinic Study of Aging were evaluated at baseline and every 15 months to identify incident MCI or dementia. Results: Over a median follow-up of 5.1 years, 153 of 534 participants (28.7{\%}) with prevalent or incident MCI progressed to dementia (71.3 per 1,000 person-years). The cumulative incidence of dementia was 5.4{\%} at 1 year, 16.1{\%} at 2, 23.4{\%} at 3, 31.1{\%} at 4, and 42.5{\%}at 5 years. The risk of dementia was elevated in MCI cases (hazard ratio [HR] 23.2, p , 0.001) compared with CN subjects. Thirty-eight percent (n 5 201) of MCI participants reverted to CN (175.0/1,000 person-years), but 65{\%} subsequently developed MCI or dementia; the HR was 6.6 (p , 0.001) compared with CN subjects. The risk of reversion was reduced in subjects with an APOE e4 allele (HR 0.53, p , 0.001), higher Clinical Dementia Rating Scale-Sum of Boxes (HR 0.56, p , 0.001), and poorer cognitive function (HR 0.56, p , 0.001). The risk was also reduced in subjects with amnestic MCI (HR 0.70, p 5 0.02) and multidomain MCI (HR 0.61, p 5 0.003). Conclusions: MCI cases, including thosewho revert to CN, have a high risk of progressing to dementia. This suggests that diagnosis of MCI at any time has prognostic value.",
author = "Roberts, {Rosebud O} and Knopman, {David S} and Mielke, {Michelle M} and Cha, {Ruth H.} and Pankratz, {V. Shane} and Christianson, {Teresa J H} and Geda, {Yonas Endale} and Boeve, {Bradley F} and Ivnik, {Robert J.} and Tangalos, {Eric George} and Rocca, {Walter A} and Petersen, {Ronald Carl}",
year = "2014",
month = "1",
day = "28",
doi = "10.1212/WNL.0000000000000055",
language = "English (US)",
volume = "82",
pages = "317--325",
journal = "Neurology",
issn = "0028-3878",
publisher = "Lippincott Williams and Wilkins",
number = "4",

}

TY - JOUR

T1 - Higher risk of progression to dementia in mild cognitive impairment cases who revert to normal

AU - Roberts, Rosebud O

AU - Knopman, David S

AU - Mielke, Michelle M

AU - Cha, Ruth H.

AU - Pankratz, V. Shane

AU - Christianson, Teresa J H

AU - Geda, Yonas Endale

AU - Boeve, Bradley F

AU - Ivnik, Robert J.

AU - Tangalos, Eric George

AU - Rocca, Walter A

AU - Petersen, Ronald Carl

PY - 2014/1/28

Y1 - 2014/1/28

N2 - Objective: To estimate rates of progression from mild cognitive impairment (MCI) to dementia and of reversion from MCI to being cognitively normal (CN) in a population-based cohort. Methods: Participants (n 5 534, aged 70 years and older) enrolled in the prospective Mayo Clinic Study of Aging were evaluated at baseline and every 15 months to identify incident MCI or dementia. Results: Over a median follow-up of 5.1 years, 153 of 534 participants (28.7%) with prevalent or incident MCI progressed to dementia (71.3 per 1,000 person-years). The cumulative incidence of dementia was 5.4% at 1 year, 16.1% at 2, 23.4% at 3, 31.1% at 4, and 42.5%at 5 years. The risk of dementia was elevated in MCI cases (hazard ratio [HR] 23.2, p , 0.001) compared with CN subjects. Thirty-eight percent (n 5 201) of MCI participants reverted to CN (175.0/1,000 person-years), but 65% subsequently developed MCI or dementia; the HR was 6.6 (p , 0.001) compared with CN subjects. The risk of reversion was reduced in subjects with an APOE e4 allele (HR 0.53, p , 0.001), higher Clinical Dementia Rating Scale-Sum of Boxes (HR 0.56, p , 0.001), and poorer cognitive function (HR 0.56, p , 0.001). The risk was also reduced in subjects with amnestic MCI (HR 0.70, p 5 0.02) and multidomain MCI (HR 0.61, p 5 0.003). Conclusions: MCI cases, including thosewho revert to CN, have a high risk of progressing to dementia. This suggests that diagnosis of MCI at any time has prognostic value.

AB - Objective: To estimate rates of progression from mild cognitive impairment (MCI) to dementia and of reversion from MCI to being cognitively normal (CN) in a population-based cohort. Methods: Participants (n 5 534, aged 70 years and older) enrolled in the prospective Mayo Clinic Study of Aging were evaluated at baseline and every 15 months to identify incident MCI or dementia. Results: Over a median follow-up of 5.1 years, 153 of 534 participants (28.7%) with prevalent or incident MCI progressed to dementia (71.3 per 1,000 person-years). The cumulative incidence of dementia was 5.4% at 1 year, 16.1% at 2, 23.4% at 3, 31.1% at 4, and 42.5%at 5 years. The risk of dementia was elevated in MCI cases (hazard ratio [HR] 23.2, p , 0.001) compared with CN subjects. Thirty-eight percent (n 5 201) of MCI participants reverted to CN (175.0/1,000 person-years), but 65% subsequently developed MCI or dementia; the HR was 6.6 (p , 0.001) compared with CN subjects. The risk of reversion was reduced in subjects with an APOE e4 allele (HR 0.53, p , 0.001), higher Clinical Dementia Rating Scale-Sum of Boxes (HR 0.56, p , 0.001), and poorer cognitive function (HR 0.56, p , 0.001). The risk was also reduced in subjects with amnestic MCI (HR 0.70, p 5 0.02) and multidomain MCI (HR 0.61, p 5 0.003). Conclusions: MCI cases, including thosewho revert to CN, have a high risk of progressing to dementia. This suggests that diagnosis of MCI at any time has prognostic value.

UR - http://www.scopus.com/inward/record.url?scp=84895735338&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84895735338&partnerID=8YFLogxK

U2 - 10.1212/WNL.0000000000000055

DO - 10.1212/WNL.0000000000000055

M3 - Article

C2 - 24353333

AN - SCOPUS:84895735338

VL - 82

SP - 317

EP - 325

JO - Neurology

JF - Neurology

SN - 0028-3878

IS - 4

ER -